NCT06311019View on ClinicalTrials.gov

The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections

NAActive, not recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

September 1, 2025

Conditions
Type 2 Diabetes Treated With Insulin
Interventions
DEVICE

Continuous glucose monitoring and use of connected insulinpen for bolus insulin

Continuous glucose monitoring (Abbott Freestyle Libre 2) and use of connected insulinpen (Novopen 6) for bolus insulin

Trial Locations (5)

7400

Gødstrup Regional Hospital, Herning

8000

Steno Diabetes Center Aarhus, Aarhus

8600

Regional Hospital Silkeborg, Central Jutland Hospital, Silkeborg

8700

Horsens Regional Hospital, Horsens

8900

Randers Regional Hospital, Randers

All Listed Sponsors
collaborator

Steno Diabetes Center Aarhus, Denmark

UNKNOWN

lead

Klavs Würgler Hansen

OTHER